
From a Westinghouse robotics business to Zer0 to 5ive and Imagine Pharma, Santiago Pujadas has spent his career connecting strategy with the work of running a company. His favorite lesson is five words long.
Ngoc L. Thai, MD, PhD is a transplant surgeon turned biotech founder who built one of the world's largest pancreas programs before chasing a hunch from a cup of his uncle's tea. As founder, co-CEO and CMO of Pittsburgh-based Imagine Pharma, he is developing IMG-1, a polypeptide first isolated from a Vietnamese tea plant, into therapies that coax insulin-producing islet cells to multiply and regenerate. The company raised a $32.5M Series A in October 2023 to advance IMG-1 across oral delivery, therapeutics, and regenerative medicine platforms aimed at type 1 diabetes, wound healing, and other underserved conditions.